PPARD and invasive ductal breast carcinoma: The synthetic PPARδ agonist (GW501516) [7] evoked rapid progression of K-RAS mutant/PPARδ+ pancreatic intraepithelial neoplasia precursor lesions to ductal adenocarcinoma in mice.